MX2018015224A - Composicion que comprende la proteina de fusion de rv2299c y esat-6 para promover la maduracion de las celulas dendriticas. - Google Patents
Composicion que comprende la proteina de fusion de rv2299c y esat-6 para promover la maduracion de las celulas dendriticas.Info
- Publication number
- MX2018015224A MX2018015224A MX2018015224A MX2018015224A MX2018015224A MX 2018015224 A MX2018015224 A MX 2018015224A MX 2018015224 A MX2018015224 A MX 2018015224A MX 2018015224 A MX2018015224 A MX 2018015224A MX 2018015224 A MX2018015224 A MX 2018015224A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- dendritic cell
- rv2299c
- esat
- fusion protein
- Prior art date
Links
- 210000004443 dendritic cell Anatomy 0.000 title abstract 5
- 108020001507 fusion proteins Proteins 0.000 title abstract 2
- 102000037865 fusion proteins Human genes 0.000 title abstract 2
- 230000035800 maturation Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 230000004041 dendritic cell maturation Effects 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 101710166488 6 kDa early secretory antigenic target Proteins 0.000 abstract 1
- 101100018084 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) htpG gene Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4648—Bacterial antigens
- A61K39/464817—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a una composición para inducir la maduración de células dendríticas y a un método para madurar células dendríticas. Más particularmente, la presente invención se refiere a una composición que incluye una proteína de fusión Rv2299c y ESAT-6, ambas derivadas de M. tuberculosis, como un ingrediente activo para inducir la maduración de células dendríticas y un método para diferenciar células dendríticas inmaduras en células dendríticas maduras utilizando el mismo. El método de la presente invención puede incrementar una respuesta inmune de células dendríticas en el cuerpo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160070517A KR101749165B1 (ko) | 2016-06-07 | 2016-06-07 | Rv2299c 또는 Rv2299c와 ESAT-6 융합한 단백질을 포함하는 수지상 세포의 성숙화 촉진용 조성물 |
| PCT/KR2017/005892 WO2017213407A1 (ko) | 2016-06-07 | 2017-06-07 | Ｒｖ２２９９ｃ와 ＥＳＡＴ-６ 융합한 단백질을 포함하는 수지상 세포의 성숙화 촉진용 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018015224A true MX2018015224A (es) | 2019-03-28 |
Family
ID=59283477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018015224A MX2018015224A (es) | 2016-06-07 | 2017-06-07 | Composicion que comprende la proteina de fusion de rv2299c y esat-6 para promover la maduracion de las celulas dendriticas. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11414646B2 (es) |
| EP (1) | EP3467102B1 (es) |
| JP (1) | JP6683892B2 (es) |
| KR (1) | KR101749165B1 (es) |
| CN (1) | CN109415700B (es) |
| AU (1) | AU2017279377B2 (es) |
| BR (1) | BR112018075291A2 (es) |
| MX (1) | MX2018015224A (es) |
| PH (1) | PH12018502533A1 (es) |
| RU (1) | RU2733886C2 (es) |
| WO (1) | WO2017213407A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102193304B1 (ko) * | 2019-10-24 | 2020-12-22 | 충남대학교산학협력단 | Rv2299c-ESAT6-HspX-RipA 융합단백질의 BCG 백신 booster용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1567155B1 (en) * | 2002-12-06 | 2010-10-27 | NorthWest Biotherapeutics, Inc. | Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| US8273357B2 (en) * | 2004-07-16 | 2012-09-25 | Massachusetts Institute Of Technology | Antigen-carbohydrate conjugates |
| CN102149822A (zh) | 2008-09-12 | 2011-08-10 | 株式会社Lg生命科学 | 用于检测结核分枝杆菌复合群或分枝杆菌属的组合物和使用所述组合物通过多重实时pcr来同时检测结核分枝杆菌复合群和分枝杆菌属的方法 |
| KR101158649B1 (ko) | 2010-05-27 | 2012-06-26 | 울산대학교 산학협력단 | 이중 실시간 중합효소연쇄반응법을 이용한 결핵균과 항산성비결핵균의 검출 방법 |
| KR20120068647A (ko) * | 2010-12-18 | 2012-06-27 | 아이진 주식회사 | 개선된 면역반응을 유도하는 백신 |
| JP5906019B2 (ja) | 2011-03-31 | 2016-04-20 | 国立大学法人福井大学 | 免疫刺激ｇ９．１の抗結核ブースターワクチン創出への応用 |
| KR101264821B1 (ko) * | 2011-07-25 | 2013-05-15 | 충남대학교산학협력단 | 결핵균의 Ｒｖ０５７７ 단백질을 이용한 수지상 세포의 성숙방법 |
| KR101270999B1 (ko) * | 2011-10-11 | 2013-06-04 | 충남대학교산학협력단 | 결핵균의 Ｒｖ２２９９ｃ 단백질을 이용한 수지상 세포의 성숙방법 |
| KR101403507B1 (ko) | 2013-03-21 | 2014-06-09 | 주식회사 현일바이오 | 결핵균 및 비결핵 마이코박테리아의 선택적 검출 방법, 그리고 이를 이용한 키트 |
-
2016
- 2016-06-07 KR KR1020160070517A patent/KR101749165B1/ko active IP Right Grant
-
2017
- 2017-06-07 CN CN201780035376.8A patent/CN109415700B/zh active Active
- 2017-06-07 RU RU2018141866A patent/RU2733886C2/ru active
- 2017-06-07 WO PCT/KR2017/005892 patent/WO2017213407A1/ko unknown
- 2017-06-07 BR BR112018075291-6A patent/BR112018075291A2/pt not_active Application Discontinuation
- 2017-06-07 EP EP17810530.0A patent/EP3467102B1/en active Active
- 2017-06-07 MX MX2018015224A patent/MX2018015224A/es unknown
- 2017-06-07 JP JP2019517746A patent/JP6683892B2/ja active Active
- 2017-06-07 AU AU2017279377A patent/AU2017279377B2/en active Active
-
2018
- 2018-11-29 US US16/204,436 patent/US11414646B2/en active Active
- 2018-11-29 PH PH12018502533A patent/PH12018502533A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017279377B2 (en) | 2020-04-30 |
| WO2017213407A1 (ko) | 2017-12-14 |
| KR101749165B1 (ko) | 2017-06-23 |
| RU2733886C2 (ru) | 2020-10-07 |
| JP6683892B2 (ja) | 2020-04-22 |
| AU2017279377A1 (en) | 2018-12-20 |
| RU2018141866A3 (es) | 2020-07-10 |
| EP3467102A1 (en) | 2019-04-10 |
| CN109415700B (zh) | 2022-04-08 |
| EP3467102A4 (en) | 2019-08-28 |
| BR112018075291A2 (pt) | 2019-04-30 |
| EP3467102B1 (en) | 2021-09-15 |
| US11414646B2 (en) | 2022-08-16 |
| JP2019521183A (ja) | 2019-07-25 |
| CN109415700A (zh) | 2019-03-01 |
| PH12018502533A1 (en) | 2019-10-21 |
| RU2018141866A (ru) | 2020-07-10 |
| US20190153390A1 (en) | 2019-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019014960A (es) | Composiciones de fosfodiesterasa de tipo 5 (pde5) y métodos de inmunoterapia. | |
| PH12018500707A1 (en) | Anti-human cd19 antibodies with high affinity | |
| MX2019007020A (es) | Anticuerpos il-11. | |
| NZ733807A (en) | Protein delivery in primary hematopoietic cells | |
| MX2017008813A (es) | Polvo de coleopteros. | |
| AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
| MY191581A (en) | Anti-pd-1 antibodies | |
| MX2016009072A (es) | Fusion de antigenos micobacterianos heterooligomericos. | |
| MY182593A (en) | Composition containing chitin and digestible proteins | |
| WO2013054199A3 (en) | Cmv antigens and uses thereof | |
| WO2016126876A3 (en) | Listeria-based adjuvants | |
| PH12015502289A1 (en) | Creamer composition comprising plant protein microparticles | |
| MX2018006489A (es) | Nanoemulsiones para bebidas producidas mediante un proceso de alto cizallamiento. | |
| PH12015501101A1 (en) | Method for eliciting an immune response to an immunogen | |
| MX2021005373A (es) | Variantes de proteinas de union al factor h y metodos de uso de estas. | |
| PH12016502002B1 (en) | Novel bacteriophage and composition comprising same | |
| PH12016501689B1 (en) | Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof | |
| MY191217A (en) | Group a streptococcus vaccine | |
| EP4316497A3 (en) | Mesenchymal stem cells as vaccine adjuvants and methods for using the same | |
| PH12020550483A1 (en) | Anti-apoc3 antibodies and methods of use thereof | |
| MY183068A (en) | Pharmaceutical formulation comprising antibody | |
| MY184391A (en) | Microorganism having improved intracellular energy level and method for producing l-amino acid using same | |
| PH12018502533A1 (en) | COMPOSITION FOR PROMOTING MATURATION OF DENDRITIC CELL CONTAINING FUSION PROTEIN OF Rv2299c AND ESAT-6 | |
| EA201790360A1 (ru) | Получение полностью процессированного и функционального фактора x в фурин-секретирующей системе экспрессии млекопитающего | |
| MX2016008821A (es) | Composiciones lacteas fermentadas coladas y aireadas. |